Kelly Londy - CEO & Operational Executive, Board of Directors

Kelly Londy is the Chief Executive Officer and Operational Executive, Board of Directors for Lumicell. She brings over 25 years of experience in the medical device field including nine years of practical and clinical experience in radiography. As a Six Sigma Blackbelt she leads the business with analytics, passion for innovation, and patient-focused solutions. Londy was the Chief Operating Officer at Accuray where she provided end-to-end leadership across all customer facing activities, from product development through customer adoption, education, and service. Londy joined Accuray in 2011 as the Executive Vice President and Chief Commercial Officer. Prior to joining Accuray, Londy also served as Vice President and General Manager of Molecular Imaging at GE Healthcare North America held multiple leadership roles at Philips Healthcare North America.


Kevin Hershberger - Chief Financial Officer 
Kevin Hershberger is the Chief Financial Officer for Lumicell. He brings over 25 years of global financial management experience in a variety of life science products and manufacturing companies with an extensive range of expertise and leadership responsibilities. Kevin most recently served as Chief Financial Officer of ReWalk Robotics where he built out the company’s finance function and launched a partnership with Harvard University’s Wyss Institute encompassing a broad licensing and collaboration agreement to develop a Softsuit Exoskeleton. Prior to ReWalk, he held leadership roles with NxStage Medical as the Vice President of Finance, Controller, and Chief Accounting Officer. Kevin also served in a variety of finance leadership roles at Boston Scientific.


W. David Lee - President & Chief Scientific Officer

David was the founding CEO of Lumicell and is now the Chief Scientific Officer. After creating T2 Biosystems (NASDAQ TTOO) he returned to the MIT Koch Institute to develop new technology that would address breast cancer which was responsible of his wife’s death. Lumicell is the embodiment of that goal.  David has over 35 years of experience translating innovation into commercial successes. As a senior vice president and managing director at Arthur D. Little (ADL), he directed the technology and product development division, one of three major ADL business lines, and personally managed over 50 development and commercialization programs during his tenure. David and his associates taught product development and commercialization skills to Fortune 500 companies including ABB, General Electric, Carrier and Analog Devices. He has a B.S. and an M.S. in Mechanical Engineering from Massachusetts Institute of Technology and completed the intensive Advanced Management Program at Harvard Business School.



Jorge Ferrer Ph.D. - Senior Vice President of Product Development

Jorge leads the company's research and development efforts including planning and overseeing the work with Lumicell’s academic collaborators, managing pre-clinical and clinical studies, and communicating and reporting to the FDA. During his post-doctoral with Dr. Moungi Bawendi at Massachusetts Institute of Technology, he developed the prototype of the Lumicell imaging system and conducted the proof-of-concept experiments in mice and dogs. He holds a Ph.D. in Biological Engineering from MIT, an M.S. in Mechanical Engineering from MIT and a B.S. in Mechanical Engineering from University of Puerto Rico Mayagüez. Prior to his post-graduate studies, Jorge worked as a Mechanical Design Engineer in the sensors and controls industry at Texas Instruments.



David Strasfeld Ph.D. -Senior Director, Research and Innovation

David is developing the next generation of Lumicell imaging devices for clinical use, pursuing new indications for the Lumicell technology and ensuring regulatory compliance throughout the development process. David holds a B.A. from Washington University in St. Louis in chemistry and a Ph.D. from the University of Wisconsin – Madison in physical chemistry. David joined Lumicell following time spent as a post-doctoral associate at Massachusetts Institute of Technology in the lab of Moungi Bawendi. David has co-authored over 20 journal articles and reviews in the fields of biophysics, molecular spectroscopy and fluorescence microscopy.